These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30142870)

  • 1. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
    Kang SJ; Mintz GS; Akasaka T; Park DW; Lee JY; Kim WJ; Lee SW; Kim YH; Whan Lee C; Park SW; Park SJ
    Circulation; 2011 Jun; 123(25):2954-63. PubMed ID: 21646494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 6. Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation　- An Optical Coherence Tomography Study.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Tomoi Y; Hiromasa T; Kobayashi Y; Domei T; Soga Y; Hyodo M; Shirai S; Ando K
    Circ J; 2017 Mar; 81(4):450-457. PubMed ID: 28132981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of LDL-C level with neoatherosclerosis and plaque vulnerability in patients with late restenosis: an optical coherence tomography study.
    Liu Z; Deng C; Zhao R; Xu G; Bai Z; Wang Z; Zhang W; Ma Y; Hu X; Jin C; Chen P; Ma S; Shi B
    Int J Cardiovasc Imaging; 2023 Dec; 39(12):2609-2619. PubMed ID: 37804387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.
    Zhang W; Zhang W; Gu N; Qiu Z; Pan L; Zhao Y; Shi B
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):646-654. PubMed ID: 38030142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.
    Habara M; Terashima M; Nasu K; Kaneda H; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Suzuki T
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):276-84. PubMed ID: 22945378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
    Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    EuroIntervention; 2017 Jun; 13(3):294-302. PubMed ID: 28320686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
    Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis　- Optical Coherence Tomography Study.
    Nakamura D; Yasumura K; Nakamura H; Matsuhiro Y; Yasumoto K; Tanaka A; Matsunaga-Lee Y; Yano M; Yamato M; Egami Y; Shutta R; Sakata Y; Tanouchi J; Nishino M
    Circ J; 2019 Jan; 83(2):313-319. PubMed ID: 30487370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.